Mangoceuticals, Inc. (MGRX)
NASDAQ: MGRX · Real-Time Price · USD
2.070
-0.310 (-13.02%)
Mar 31, 2025, 10:57 AM EDT - Market open

Mangoceuticals Statistics

Total Valuation

Mangoceuticals has a market cap or net worth of $10.70 million. The enterprise value is $12.46 million.

Market Cap 10.70M
Enterprise Value 12.46M

Important Dates

The last earnings date was Thursday, March 20, 2025, after market close.

Earnings Date Mar 20, 2025
Ex-Dividend Date n/a

Share Statistics

Mangoceuticals has 5.17 million shares outstanding. The number of shares has increased by 84.23% in one year.

Current Share Class 5.17M
Shares Outstanding 5.17M
Shares Change (YoY) +84.23%
Shares Change (QoQ) +30.13%
Owned by Insiders (%) 13.16%
Owned by Institutions (%) 1.77%
Float 3.64M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 7.65
Forward PS n/a
PB Ratio 0.55
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 20.23
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.05, with a Debt / Equity ratio of 0.02.

Current Ratio 0.05
Quick Ratio 0.04
Debt / Equity 0.02
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -601.44

Financial Efficiency

Return on equity (ROE) is -118.31% and return on invested capital (ROIC) is -68.38%.

Return on Equity (ROE) -118.31%
Return on Assets (ROA) -62.72%
Return on Invested Capital (ROIC) -68.38%
Return on Capital Employed (ROCE) -59.09%
Revenue Per Employee $205,291
Profits Per Employee -$3.19M
Employee Count 3
Asset Turnover 0.08
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -27.55% in the last 52 weeks. The beta is 1.51, so Mangoceuticals's price volatility has been higher than the market average.

Beta (5Y) 1.51
52-Week Price Change -27.55%
50-Day Moving Average 3.81
200-Day Moving Average 3.74
Relative Strength Index (RSI) 34.67
Average Volume (20 Days) 249,194

Short Selling Information

The latest short interest is 72,618, so 1.40% of the outstanding shares have been sold short.

Short Interest 72,618
Short Previous Month 62,722
Short % of Shares Out 1.40%
Short % of Float 1.99%
Short Ratio (days to cover) 0.97

Income Statement

In the last 12 months, Mangoceuticals had revenue of $615,873 and -$9.58 million in losses. Loss per share was -$4.84.

Revenue 615,873
Gross Profit 379,964
Operating Income -8.24M
Pretax Income -9.02M
Net Income -9.58M
EBITDA -7.51M
EBIT -8.24M
Loss Per Share -$4.84
Full Income Statement

Balance Sheet

The company has $58,653 in cash and $214,962 in debt, giving a net cash position of -$156,309 or -$0.03 per share.

Cash & Cash Equivalents 58,653
Total Debt 214,962
Net Cash -156,309
Net Cash Per Share -$0.03
Equity (Book Value) 13.95M
Book Value Per Share 4.30
Working Capital -1.35M
Full Balance Sheet

Cash Flow

Operating Cash Flow -4.86M
Capital Expenditures n/a
Free Cash Flow -4.86M
FCF Per Share -$0.94
Full Cash Flow Statement

Margins

Gross Margin 61.70%
Operating Margin -1,337.90%
Pretax Margin -1,413.80%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

Mangoceuticals does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -84.23%
Shareholder Yield -84.23%
Earnings Yield -77.86%
FCF Yield -39.54%

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a

Stock Splits

The last stock split was on October 16, 2024. It was a reverse split with a ratio of 0.0666667:1.

Last Split Date Oct 16, 2024
Split Type Reverse
Split Ratio 0.0666667:1

Scores

Mangoceuticals has an Altman Z-Score of -0.63 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -0.63
Piotroski F-Score 2